138 related articles for article (PubMed ID: 23851463)
1. Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis.
Rampazzo E; Voltan R; Petrizza L; Zaccheroni N; Prodi L; Casciano F; Zauli G; Secchiero P
Nanoscale; 2013 Sep; 5(17):7897-905. PubMed ID: 23851463
[TBL] [Abstract][Full Text] [Related]
2. Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels.
Wang K; He X; Yang X; Shi H
Acc Chem Res; 2013 Jul; 46(7):1367-76. PubMed ID: 23489227
[TBL] [Abstract][Full Text] [Related]
3. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
He X; Nie H; Wang K; Tan W; Wu X; Zhang P
Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
[TBL] [Abstract][Full Text] [Related]
4. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
6. Flotillin-involved uptake of silica nanoparticles and responses of an alveolar-capillary barrier in vitro.
Kasper J; Hermanns MI; Bantz C; Utech S; Koshkina O; Maskos M; Brochhausen C; Pohl C; Fuchs S; Unger RE; Kirkpatrick CJ
Eur J Pharm Biopharm; 2013 Jun; 84(2):275-87. PubMed ID: 23183446
[TBL] [Abstract][Full Text] [Related]
7. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
8. Clathrin-mediated endocytosis is involved in uptake and toxicity of silica nanoparticles in Caenohabditis elegans.
Eom HJ; Choi J
Chem Biol Interact; 2019 Sep; 311():108774. PubMed ID: 31369748
[TBL] [Abstract][Full Text] [Related]
9. Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size.
Lee K; Lee J; Kwak M; Cho YL; Hwang B; Cho MJ; Lee NG; Park J; Lee SH; Park JG; Kim YG; Kim JS; Han TS; Cho HS; Park YJ; Lee SJ; Lee HG; Kim WK; Jeung IC; Song NW; Bae KH; Min JK
J Nanobiotechnology; 2019 Feb; 17(1):24. PubMed ID: 30722792
[TBL] [Abstract][Full Text] [Related]
10. Herceptin functionalized polyhedral oligomeric silsesquioxane - conjugated oligomers - silica/iron oxide nanoparticles for tumor cell sorting and detection.
Mi Y; Li K; Liu Y; Pu KY; Liu B; Feng SS
Biomaterials; 2011 Nov; 32(32):8226-33. PubMed ID: 21816464
[TBL] [Abstract][Full Text] [Related]
11. Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells.
Gualtieri M; Skuland T; Iversen TG; Låg M; Schwarze P; Bilaničová D; Pojana G; Refsnes M
Nanotoxicology; 2012 Nov; 6(7):700-12. PubMed ID: 21793771
[TBL] [Abstract][Full Text] [Related]
12. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.
Liu C; Yu W; Chen Z; Zhang J; Zhang N
J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765
[TBL] [Abstract][Full Text] [Related]
13. Assessment of temporal dose-toxicity relationship of fumed silica nanoparticle in human lung A549 cells by conventional cytotoxicity and ¹H-NMR-based extracellular metabonomic assays.
Irfan A; Cauchi M; Edmands W; Gooderham NJ; Njuguna J; Zhu H
Toxicol Sci; 2014 Apr; 138(2):354-64. PubMed ID: 24449423
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery.
Andreani T; de Souza AL; Kiill CP; Lorenzón EN; Fangueiro JF; Calpena AC; Chaud MV; Garcia ML; Gremião MP; Silva AM; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):627-35. PubMed ID: 25089510
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent non-porous silica nanoparticles for long-term cell monitoring: cytotoxicity and particle functionality.
Soenen SJ; Manshian B; Doak SH; De Smedt SC; Braeckmans K
Acta Biomater; 2013 Nov; 9(11):9183-93. PubMed ID: 23664886
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
He X; Hai L; Su J; Wang K; Wu X
Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier.
Liu D; Lin B; Shao W; Zhu Z; Ji T; Yang C
ACS Appl Mater Interfaces; 2014 Feb; 6(3):2131-6. PubMed ID: 24417514
[TBL] [Abstract][Full Text] [Related]
19. Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent.
Blechinger J; Bauer AT; Torrano AA; Gorzelanny C; Bräuchle C; Schneider SW
Small; 2013 Dec; 9(23):3970-80, 3906. PubMed ID: 23681841
[TBL] [Abstract][Full Text] [Related]
20. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
